Spineart and eCential Robotics today announced the receipt of FDA 510(k) clearance for the use of an application for robotic ...
FOR IMMEDIATE RELEASESpineart and eCential Roboticsannounce FDA clearance of PERLA® App for use with Op.nTM robotic navigation platformDallas, ...
The FDA has cleared Spineart’s Perla TL application for use with eCential Robotics Op.nTM robotic navigation platform. The clearance will combine Spineart and eCential Robotics’ robotic-assisted spine ...
Dallas, Texas and Franklin, Tennessee, March 13, 2025 — Spineart, a fast-growing company in spine surgery innovation, and eCential Robotics, an expert company in surgical robotics, proudly ...
Interim analysis of 1-level BAGUERA®C IDE study meets threshold for non-inferiorityGeneva, March 11, 2025 – Spineart, a fast-growing company in ...
Geneva, March 11, 2025 – Spineart, a fast-growing company in spine surgery innovation, today announces that it has completed a planned interim analysis for its 1-level BAGUERA®C IDE study ...
Dallas, Texas and Franklin, Tennessee, March 13, 2025 — Spineart, a fast-growing company in spine surgery innovation, and eCential Robotics, an expert company in surgical robotics, proudly announce ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback